Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xenograft Enhanced With Hydrogel in Augmentation of the Maxillary Sinus
NCT07737704Phase 3Recruiting
- Sponsor
- Misr International University
- Start
- Aug 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Phase 3, randomised trial in Alveolar bone loss (2 arms), sponsored by Misr International University. Primary endpoint: Bone height gain at 8 months. Started Aug 2026; status: recruiting.
02
Conditions
Alveolar bone loss
Beyond the preview
Go deeper on NCT07737704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07737704.